| | | | | | Catalent Acquires Premier European Product Launch Site from Bristol-Myers Squibb | |
|
| | | | | Catalent recently announced the completion of its acquisition of Bristol-Myers Squibb’s biologics, sterile, and oral solid dose product manufacturing and packaging facility in Anagni, Italy.
The state-of-the-art facility, designed for late-phase tech transfers and commercial product launches, has a track record of launching hundreds of new products across many therapies including cardiovascular, cancer, and hepatitis treatments. The facility provides Catalent customers access to: |
|
|---|
| | |
| | | Comprehensive commercial packaging solutions, with blister and bottling capabilitiesSerialization solutions to ensure product traceability throughout the global supply chainIntegrated digital printing and RFID tracking Automated warehousing The Anagni facility complements Catalent’s existing European biologics, oral solid dose development and manufacturing network. |
|
| |
| | | | | | | Catalent Celebrates Fifth Anniversary of its IPO, by Ringing the NYSE Closing Bell | |
|
| | | | | | | On January 2, members of Catalent's Executive Leadership Team celebrated the company's 5-year IPO anniversary by ringing the closing bell at the New York Stock Exchange. "During our IPO, we were 8,500 people. Fast forward five years: we are 13,000 strong with $2.5B in annual revenue and a heartbeat of helping people live better, healthier lives." Said Catalent’s Chairman and CEO, John Chiminski. |
|
|---|
| | |
| | | | | | | | | Catalent Further Strengthens Biologics Business with Key Senior Appointments |
|
| |
| | | | | Catalent announced the appointment of Karen Flynn as President of Biologics and Chief Commercial Officer. Ms. Flynn takes on the role previously held by Mr. Barry Littlejohns, who will be retiring. In addition, Catalent has promoted Mike Riley to Region President, Biologics North America, and Manja Boerman as Region President, Biologics Europe, where each will lead all development, manufacturing, and commercial activity in their respective regions, as well as growing Catalent Biologics’ business. |
|
| |
| | | | | | | | | | | Join Catalent at WCBP 2020 |
|
| |
| | | | | Visit Catalent in Washington, D.C. and stop by our stand 18 to speak with our experts during the show. On January 28, at 12:50 p.m., we invite you to our technical seminar presented by Christopher Hepler Manager, Lab Operations, Catalent Biologics titled “Conversion of a Potency Assay from Cell-Based Binding to AlphaLISA”. |
|
|---|
| | |
| | | The presentation, on January 28 at 12:50 p.m., will outline how this assay method was not only significantly more accurate and less variable than the original FACS assay, it was also overwhelmingly easier and faster to execute. Schedule a meeting with one of our Biologics experts during this event.
|
|
| |
| | | | | | | | | Natural Products Expo West |
|
| |
| | | | | Join Catalent in Anaheim, California for Natural Products Expo West. Visit our booth 4183 from March 3 – 7, 2020 and learn about our growing capabilities to support plant-based dosage forms for the nutritional supplement industry. Learn about our Vegicaps® capsules solution for consumers seeking a plant-based alternative to gelatin capsules. |
|
|---|
| | |
| | | | | | | | | A Catalyst in Drug Development | |
|
| | | | | Christopher Hepler
Manager, Lab Operations, Catalent Biologics
|
|
| |
| | | | | | | Christopher specializes in potency assay (Bioassay, ELISA) and molecular biology (PCR/qPCR and cell engineering) development and validation for product release and stability testing. He works out of Catalent’s Research Triangle Park facility in Morrisville, North Carolina. Christopher will speak at the upcoming WCBP event where he will present “Conversion of a Potency Assay from Cell-Based Binding to AlphaLISA”. Discover what drives his passion for Bio-Analytical research. Access his works that include nine peer-reviewed articles, and additional content to help you in your research development. |
|
|---|
| | |
| | | | | | | | | BIOLOGICS Webinar: “You’ve got that coveted accelerated regulatory pathway. Now what?” - In this webcast, John Carrol, Founder and Editor of EndPoints News speaks with industry veterans from Alnylam Pharma, Urogen Pharma, Mirum Pharmaceuticals, and Catalent Biologics, about the pitfalls present in any accelerated development challenge, and how to avoid them. Video: “GPEx® Boost: The Next Generation of Cell Line Development” - The next generation of cell line development, designed to improve productivity by leveraging proven GPEx® technology with multiple enhancements, including utilization of a glutamine synthetase (GS) knock-out Chinese hamster ovary (CHO) cell line. Poster: “A Brief Evaluation of the Impact of Thermal, Shear, and Light Stress on Adalimumab” - The propensity of a protein to degrade under stress can vary widely among proteins and is important to understand in pharmaceutical development. A model protein, adalimumab, was tested by a limited set of techniques after subjection to thermal, shear and light stresses. |
|
|---|
| | |
| | | | | | | CLINICAL SUPPLY / CLINICAL SERVICES Webinar: “The Art of Recognizing Clinical Supply Risk Factors” - Learn about applying proactive measures to avoid delays in clinical study. Watch the webinar on aspects of the study protocol that can directly influence clinical supply strategy and taking appropriate steps to address challenges early on.Video: “Catalent Softgel Marks Milestone in China” - Catalent continues to expand its global leadership by providing access to drug delivery and clinical trial capabilities for customers in Asia Pacific. Case Study: “Expediting Path to Clinic with OptiForm® Total Supply” – Learn how Catalent provided integrated formulation development, clinical trial material manufacturing, and supply and distribution services that ensured successful delivery of MGB Biopharma kits to its patients. |
|
|---|
| | |
| | | | | | | ORAL DRUG DELIVERY Presentation: “How to Effectively Work with a Development Partner – From a Consultant Standpoint” - Drug development requires integrating multi-disciplinary scientific, business and regulatory activities. To successfully support a client’s program, it is important to provide advice and services that support all three in the context of a program’s goal. Hear case studies presented in characterization and formulation of oral small molecule drugs that can help your clients succeed. Video: “Unlock Your Molecule’s Potential with Catalent” - Your molecule has so much potential, we share the passion to unlock it through extensive expertise and superior formulation technologies. Learn how we have optimized thousands of molecules from pre-formulation through development. Executive Summary: “Overcoming Manufacturing Challenges for Accelerated Drug Development” - Learn how to leverage drug development knowledge and build a strategy that maintains integrity, quality, and timeliness of the manufacturing process. Get expert insights on overcoming manufacturing challenges associated with expedited development and stability programs. |
|
|---|
| | |
| | | | | | | CONSUMER HEALTH Webinar: “ OTC Innovation to Avoid Stagnation” – What are the critical factors for OTC products to achieve consumer engagement and retail success? Watch the webinar to get insights from industry experts on the critical role of innovation in OTC products and strategies for achieving it, including key learnings from an industry survey, market trends from Nicolas Hall Companies and insights on technologies for creating innovative dosage forms. Video: “Launch Your Next OTC Product Faster with Catalent’s Product Library” - Catalent has built an extensive product library with more than 500 proactively developed formulations. Explore the resources for OTC brand and category managers to get a head start on product launch activities and to bring innovative products to market faster. eBook: “Innovations in Omega-3 Supplements” - Get expert insights on the latest advances in omega-3 delivery technology and explore new supplement ingredients that support brain, eye, and joint health.
|
|
|---|
| | |
| | | | | | | | | | | Your expertise, coupled with Catalent’s advanced technologies and collaboration with thousands of innovative pharmaceutical, biotech and healthcare companies, will help bring life-enhancing products to the people you know and love. Our teams are rapidly growing in Harmans, Maryland, Madison, Wisconsin, Schorndorf, Germany and multiple other locations. Apply today! Hear what our employees have to say about working at Catalent here. |
|
|---|
| | |
| | | | | | Upcoming Expert Presentations, Webinars and Events | |
|
| | | | | CASS WCBP | January 28-30, 2020 | Washington, D.C. | USA Webinar | The Do’s and Don’ts of Managing a Pivotal Gene Therapy Trial | January 28, 2020 Natural Product Expo West | March 3–7, 2020 | Anaheim, California | USA Setting Up Your Small Molecules and Biologics for Success: Development Consideration from Candidate Selection to Phase 1 | March 5, 2020 | Tel Aviv, Israel CTS Europe | March 11-12, 2020 | Madrid, Spain Achieving Integrated Biologics Development: Challenges and How to Tackle Them | March 12, 2020 | London, UK Outsourcing Clinical Trials Israel 2020 | March 17-18, 2020 | Tel Aviv, Israel DCAT Week | March 23-26, 2020 | New York City | USA
|
|
| |
| | | | | | Every brand has a challenge. We have a solution. |
| | | | | | | | or call +1 877 891 9609 to speak with one of our experts today! |
| | |
| | | To unsubscribe or manage your subscriptions, please click here.
For more information call +1-866-720-3148 or in Europe 00800 88 55 6178, email us at [email protected], or visit our website www.catalent.com. And to learn more about Career opportunities across our global network, visit www.catalent.com/careers.
Catalent Pharma Solutions respects your privacy.
Links to third party sites are provided as a convenience only. Catalent makes no representation or warranty about the technology, security or any content available at these sites. Links are not intended to imply Catalent's affiliation or endorsement or the website, its owner(s) or the content. | | © 2020, Catalent Pharma Solutions, Inc. 14 Schoolhouse Road, Somerset, NJ 08873. All rights reserved. |
|
|
